Literature DB >> 24490732

AGR2, ERp57/GRP58, and some other human protein disulfide isomerases.

S S Shishkin1, L S Eremina, L I Kovalev, M A Kovaleva.   

Abstract

This review considers the major features of human proteins AGR2 and ERp57/GRP58 and of other members of the protein disulfide isomerase (PDI) family. The ability of both AGR2 and ERp57/GRP58 to catalyze the formation of disulfide bonds in proteins is the parameter most important for assigning them to a PDI family. Moreover, these proteins and also other members of the PDI family have specific structural features (thioredoxin-like domains, special C-terminal motifs characteristic for proteins localized in the endoplasmic reticulum, etc.) that are necessary for their assignment to a PDI family. Data demonstrating the role of these two proteins in carcinogenesis are analyzed. Special attention is given to data indicating the presence of biomarker features in AGR2 and ERp57/GRP58. It is now thought that there is sufficient reason for studies of AGR2 and ERp57/GRP58 for possible use of these proteins in diagnosis of tumors. There are also prospects for studies on AGR2 and ERp57/GRP58 leading to developments in chemotherapy. Thus, we suppose that further studies on different members of the PDI family using modern postgenomic technologies will broaden current concepts about functions of these proteins, and this will be helpful for solution of urgent biomedical problems.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24490732     DOI: 10.1134/S000629791313004X

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  8 in total

1.  Increased ERp57 Expression in HBV-Related Hepatocellular Carcinoma: Possible Correlation and Prognosis.

Authors:  Miao Liu; Lingyao Du; Zhiliang He; Libo Yan; Ying Shi; Jin Shang; Hong Tang
Journal:  Biomed Res Int       Date:  2017-03-08       Impact factor: 3.411

2.  Expression of protein disulfide isomerase family members correlates with tumor progression and patient survival in ovarian cancer.

Authors:  Soma Samanta; Shuzo Tamura; Louis Dubeau; Paulette Mhawech-Fauceglia; Yohei Miyagi; Hisamori Kato; Rich Lieberman; Ronald J Buckanovich; Yvonne G Lin; Nouri Neamati
Journal:  Oncotarget       Date:  2017-10-06

Review 3.  Trefoil Factor Family (TFF) Peptides and Their Diverse Molecular Functions in Mucus Barrier Protection and More: Changing the Paradigm.

Authors:  Werner Hoffmann
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923

4.  TP53 mediated miR-3647-5p prevents progression of cervical carcinoma by targeting AGR2.

Authors:  Ronghua Liu; Min Qian; Ting Zhou; Pengfei Cui
Journal:  Cancer Med       Date:  2019-08-22       Impact factor: 4.452

5.  Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy.

Authors:  Jing Zhang; Kai Wang; Tuersun Hainisayimu; Hui Li
Journal:  Oxid Med Cell Longev       Date:  2022-08-22       Impact factor: 7.310

Review 6.  Trefoil Factor Family (TFF) Peptides and Their Links to Inflammation: A Re-evaluation and New Medical Perspectives.

Authors:  Werner Hoffmann
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

7.  LEDGF/p75 Overexpression Attenuates Oxidative Stress-Induced Necrosis and Upregulates the Oxidoreductase ERP57/PDIA3/GRP58 in Prostate Cancer.

Authors:  Anamika Basu; Christina K Cajigas-Du Ross; Leslimar Rios-Colon; Melanie Mediavilla-Varela; Tracy R Daniels-Wells; Lai Sum Leoh; Heather Rojas; Hiya Banerjee; Shannalee R Martinez; Stephanny Acevedo-Martinez; Carlos A Casiano
Journal:  PLoS One       Date:  2016-01-15       Impact factor: 3.240

8.  Upregulation of ERp57 promotes clear cell renal cell carcinoma progression by initiating a STAT3/ILF3 feedback loop.

Authors:  Yan Liu; Jian-Xing Wang; Zi-Yuan Nie; Yue Wen; Xin-Ju Jia; Li-Na Zhang; Hui-Jun Duan; Yong-Hong Shi
Journal:  J Exp Clin Cancer Res       Date:  2019-10-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.